10th World Cancer Congress - 2027

WELCOME TO MUMBAI FOR 10TH WORLD CANCER CONGRESS - 2027

We are pleased to invite oncologists, researchers, clinicians, healthcare professionals, academicians, industry experts, and students from across the globe to attend the 10th World Cancer Congress (WCC) – 2027, scheduled to take place on 13 – 14 March 2027 in Mumbai, India.

Theme:- Early Detection, Screening & Cancer Prevention Strategies

The milestone 10th edition of the World Cancer Congress will focus on Early Detection, Screening, and Cancer Prevention Strategies, highlighting innovative research, public health initiatives, advanced screening tools, and preventive oncology approaches aimed at reducing the global cancer burden.

This international congress will serve as a premier platform for sharing cutting-edge scientific insights, clinical advancements, and real-world solutions while fostering global collaboration and meaningful networking.

Join us in Mumbai, India’s financial and healthcare hub, for this landmark event as we work collectively toward earlier diagnosis, effective prevention, and improved cancer outcomes worldwide.

We look forward to welcoming you to the 10th World Cancer Congress – 2027.

Focus of the Conference

10th World Cancer Congress – 2027 | Mumbai, India

The 10th World Cancer Congress (WCC) – 2027 is dedicated to advancing global scientific, clinical, and public health efforts in early cancer detection, population-based screening, and cancer prevention strategies. The congress serves as an international platform to accelerate collaboration among researchers, clinicians, diagnostic experts, public health professionals, and industry leaders working toward reducing cancer incidence, mortality, and late-stage diagnosis.

Cancer remains one of the leading causes of morbidity and mortality worldwide, with millions of new cases diagnosed annually. Scientific evidence shows that early-stage detection can improve survival rates by up to 70–90% for several major cancers such as breast, cervical, colorectal, oral, and lung cancers. However, delayed diagnosis and limited access to screening continue to pose significant challenges, particularly in low- and middle-income regions.

WCC-2027 emphasizes a paradigm shift from treatment-centered oncology to prevention-focused, risk-based, and precision early detection approaches supported by scientific evidence and technological innovation.

The congress will focus on advances in screening and diagnostic technologies, including molecular diagnostics, liquid biopsy, genomic and epigenomic biomarkers, next-generation sequencing, AI-assisted imaging, digital pathology, and point-of-care diagnostic tools. Sessions will also explore cancer epidemiology, genetic susceptibility, hereditary cancer syndromes, and real-world implementation of national and regional screening programs.

WCC-2027 will further address primary and secondary cancer prevention by examining modifiable risk factors such as tobacco use, infections, environmental exposure, obesity, physical inactivity, and dietary patterns. Key scientific discussions will include HPV and HBV vaccination, chemoprevention, lifestyle and nutritional interventions, and integrative approaches incorporating Ayurveda, Yoga, and Naturopathy.

The congress welcomes oncologists, radiologists, pathologists, molecular diagnosticians, geneticists, epidemiologists, public health experts, AYUSH practitioners, academicians, biomedical scientists, industry professionals, policymakers, trainees, and students to participate in high-impact scientific exchange and collaborative learning.

By fostering partnerships between research institutions, healthcare systems, diagnostic innovators, and pharmaceutical and biotechnology industries, the 10th World Cancer Congress – 2027 aims to translate scientific discoveries into scalable screening models and preventive strategies, shaping the future of early detection and cancer prevention worldwide.

Key Scientific Tracks

10th World Cancer Congress – 2027 | Mumbai, India

The 10th World Cancer Congress (WCC) – 2027 features comprehensive, multidisciplinary scientific tracks designed to address early detection, screening, cancer prevention, and precision oncology. Each track brings together global expertise from research, clinical practice, public health, and innovation.

Core Conference Tracks

1. Early Cancer Detection & Screening:-  Population-based screening programs, early diagnosis strategies, risk stratification models, and implementation science.
2. Cancer Prevention & Risk Reduction:-  Lifestyle modification, tobacco control, infection-related cancers, HPV & HBV vaccination, chemoprevention, and environmental risk factors.
3. Cancer Epidemiology & Public Health Oncology:-  Global cancer burden, surveillance systems, health equity, policy development, and national cancer control programs.
4. Molecular Diagnostics & Cancer Biomarkers:- Genomics, proteomics, epigenetics, liquid biopsy, early detection biomarkers, and companion diagnostics.
5. Precision Prevention & Genomic Screening:-  Hereditary cancer syndromes, genetic counseling, polygenic risk scores, and personalized screening strategies.
6. Artificial Intelligence & Digital Oncology:-  AI-assisted imaging, machine learning in diagnostics, digital pathology, big data analytics, and decision-support systems.
7. Organ-Specific Cancers:-  Breast, cervical, lung, colorectal, oral, prostate, gynecologic, gastrointestinal, and pediatric cancers.
8. Oncology Nursing, Supportive Care & Survivorship:-  Patient-centered care, psycho-oncology, rehabilitation, quality of life, and survivorship planning.
9. Translational Research & Clinical Trials:-  Bench-to-bedside research, early-phase trials, real-world evidence, and clinical implementation of innovations.

Abstract Submission

10th World Cancer Congress - 2027 | Mumbai, India

Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should contain sufficient detail on the techniques used and the results. You will receive a confirmation when the abstract has been received. Please contact the conference secretariat if you do not receive confirmation within 5 working days. Submission implies the intent of at least one author to register, attend the symposium, and present the paper (either 12+3 minutes orally or in poster format). Contributions will only be finally accepted after registration and payment of the conference fee.

For submitting your abstract you can upload it using the form below or alternatively by sending it to info@worldcancercongress.in.

Registration Requirement

Registration for the conference is mandatory prior to abstract submission. If an abstract is not accepted, the author may write to the organizing committee for refund-related queries, as per conference policy.

Abstract Categories

Abstracts should be related to oncology, cancer prevention, screening, diagnosis, and treatment, and may be submitted under the following categories:

• Cancer Screening and Early Detection
• Breast Cancer
• Head & Neck Cancer
• Thoracic Malignancies
• Gastrointestinal Malignancies
• Gynecological Malignancies
• Urological Malignancies
• Bone & Soft Tissue Tumors
• Pediatric Oncology
• Hemato-Lymphoid Malignancies
• Molecular Oncology & Precision Medicine
• Cancer Prevention & Epidemiology
• Palliative, Supportive & Survivorship Care
• Innovations in Cancer Diagnostics & Therapeutics
• Artificial Intelligence & Digital Health in Oncology
• Integrative Oncology (AYUSH, Lifestyle & Nutrition)
• Public Health, Policy & Health Economics
• Patient Advocacy & Quality of Life

Important Dates

1st Phase Abstract Submission Closes: 17th September, 2026

2nd Phase Abstract Submission Closes: 15th November, 2026

3rd Phase Abstract Submission Closes: 19th January, 2027